The goal of the funding is to spur innovation at the intersection of AI, technology and ageing.
Researchers at the University of Southern California have developed an AI model capable of accurately capturing cognitive decline by measuring how fast the brain is ageing. ...
The US Food and Drug Administration (FDA) has approved lecanemab – a breakthrough drug for patients in the earliest stages of Alzheimer’s disease. Developed by Japanese...
Could the AI algorithms behind ChatGTP help doctors detect Alzheimer’s disease?
‘Single-cell profiling’ is helping neuroscientists see how disease affects major brain cell types and identify common, potentially targetable pathways. After decades of fundamental scientific and drug...
The tool has been designed to reduce disparities in pre-dementia and dementia diagnosis among different demographics.
Dementia hinders the ability of patients and caregivers to manage blood sugar levels.
A new drug which has been shown to slow cognitive decline in Alzheimer’s will be ‘welcome news’ for millions of patients.
Researchers in the US are exploring the use of machine learning to predict the advancement of Alzheimer’s disease and give a more accurate timeline of progression....
Ascentys has secured funding to trial its gaming and AI technology to support early screening of Alzheimer’s disease.
